80
Ras inhibitor_Ras mutation related Cancer
Oxford University
Small molecule
Oncology
Hit To Lead or Lead Optimization
University of Oxford researchers have developed small molecule inhibitors of Ras proteins, important therapeutic targets in a large number of cancers.
PCT-GB2019-050198
PCT-GB2019-050200